RayzeBio Inc. Common Stoc... (RYZB)

NASDAQ: RYZB · Real-Time Price · USD

62.49

0.01 (0.02%)

At close: Feb 23, 2024, 9:00 PM

RayzeBio Common Stock Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q3 2023	Q4 2022	Q3 2022
Period Ending	Sep 30, 2023	Dec 31, 2022	Sep 30, 2022
Net Income	-53.34M	-35.15M	-20.45M
Depreciation & Amortization	1.32M	823K	404K
Stock-Based Compensation	6.12M	3.55M	1.45M
Other Working Capital	1.97M	1.9M	-296K
Other Non-Cash Items	6.78M	6.72M	6.64M
Deferred Income Tax	-3.14M	-867K	23K
Change in Working Capital	1.97M	1.9M	-296K
Operating Cash Flow	-40.28M	-23.02M	-12.23M
Capital Expenditures	-18.93M	-5.41M	-2.6M
Cash Acquisitions	n/a	n/a	n/a
Purchase of Investments	-246.75M	-129.74M	-32.85M
Sales Maturities Of Investments	121.36M	66.36M	41.96M
Other Investing Acitivies	n/a	n/a	n/a
Investing Cash Flow	-144.32M	-68.78M	6.5M
Debt Repayment	n/a	n/a	n/a
Common Stock Repurchased	-43K	-43K	-12K
Dividend Paid	n/a	n/a	n/a
Other Financial Acitivies	470.88M	159.33M	159.68M
Financial Cash Flow	470.88M	159.33M	159.68M
Net Cash Flow	286.28M	67.53M	153.95M
Free Cash Flow	-59.22M	-28.43M	-14.83M